• V. Lysenko Zaporizhzhia State Medical University, Ukraine
  • V. Syvolap Zaporizhzhia State Medical University, Ukraine



Chronic heart failure (CHF)


Chronic heart failure (CHF) remains a major burden due to low quality of life, high morbidity, and mortality. An important aspect in the management of heart failure is to provide clinicians necessary knowledge and resources to make better decisions about treatment tactics of such patients. Thus, finding out independent predictors of adverse outcomes of heart failure is still insufficiently studied, and become an important task of internal medicine and cardiology.

Author Biographies

V. Lysenko , Zaporizhzhia State Medical University, Ukraine

MD, Postgraduate student of Department of  Propaedeutic of Internal Medicine, Radial diagnostic and Radial therapy,  Faculty of Medicine

V. Syvolap , Zaporizhzhia State Medical University, Ukraine

MD, PhD, DSci, Professor, Head of Department of Propaedeutic of Internal Medicine,  radial diagnostic and radial therapy, Faculty of Medicine


McGranaghan P., Saxena A., Düngen H.D., et al. Performance of a cardiac lipid panel compared to four prognostic scores in chronic heart failure. Sci Rep. 2021;11(1):8164. Published 2021 Apr 14. doi:10.1038/s41598-021-87776-w

Sciomer S., Moscucci F., Salvioni E., et al. Role of gender, age and BMI in prognosis of heart failure. Eur J Prev Cardiol. 2020;27(2_suppl):46-51.

Carbone S., Lavie C.J., Elagizi A., et al. The Impact of Obesity in Heart Failure. Heart Fail Clin. 2020;16(1):71-80. doi:10.1016/j.hfc.2019.08.008 4. Voronkov, L. H., Amosova, K. M., Bahriy, A. E. et al. Rekomendatsiyi z diahnostyky ta likuvannya khronichnoyi sertsevoyi nedostatnosti [Recommendations for the diagnosis and treatment of chronic heart failure]. Sertseva nedostatnistʹ.,2017; dodatok 1:1–66. [in Ukranian].

Baldasseroni S., Urso R., Orso F., et al. Relation between serum sodium levels and prognosis in outpatients with chronic heart failure: neutral effect of treatment with beta-blockers and angiotensinconverting enzyme inhibitors: data from the Italian Network on Congestive Heart Failure (IN-CHF database). J Cardiovasc Med (Hagerstown). 2011; 12(10): 723-731.

Su Y., Ma M., Zhang H., et al. Prognostic value of serum hyponatremia for outcomes in patients with heart failure with preserved ejection fraction: An observational cohort study. Exp Ther Med. 2020;20(5):101.

Rich J.D., Burns J., Freed B.H., et al. MetaAnalysis Global Group in Chronic (MAGGIC) Heart Failure Risk Score: Validation of a Simple Tool for the Prediction of Morbidity and Mortality in Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2018;7(20): e009594.

Chen X., Savarese G., Dahlström U., et al. Age-dependent differences in clinical phenotype and prognosis in heart failure with mid-range ejection compared with heart failure with reduced or preserved ejection fraction. Clin Res Cardiol. 2019;108(12):1394-1405.

Lashkul, D. A. Predyktory rozvytku nespryiatlyvykh podii u khvorykh na khronichnu sertsevu nedostatnist ishemichnoho henezu zi znyzhenoiu fraktsiieiu vykydu livoho shlunochka ta nyrkovoiu dysfunktsiieiu [Predictors of adverse events in patients with ischemic chronic heart failure with reduced ejection fraction and renal dysfunction]. Zaporozhye medical journal, 2016; 96(3):4-9. 1210.2016.3.76914 [in Ukrainian].

Kim Y.H., Han K.D., Jung J.H., et al. Weight change and the incidence of heart failure in the Korean population: data from the National Health Insurance Health checkup 2005-2015 [published online ahead of print, 2020 Nov 5]. Eur J Prev Cardiol. 2020; zwaa049. doi:10.1093/eurjpc/zwaa049

Bennett S., Wong C.W., Griffiths T., et al. The prognostic value of Tei index in acute myocardial infarction: a systematic review. Echo Res Pract. 2020;7(4):49-58. 12. Strange G., Stewart S., Celermajer D., et al. Poor Long-Term Survival in Patients With Moderate

Aortic Stenosis. J Am Coll Cardiol. 2019;74(15):1851-1863.